BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Maric H, Supic G, Kandolf-Sekulovic L, Maric V, Mijuskovic Z, Radevic T, Rajovic M, Magic Z. DNMT1 and DNMT3B genetic polymorphisms affect the clinical course and outcome of melanoma patients. Melanoma Res 2019;29:596-602. [PMID: 30950914 DOI: 10.1097/CMR.0000000000000612] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Gupta R, Janostiak R, Wajapeyee N. Transcriptional regulators and alterations that drive melanoma initiation and progression. Oncogene 2020;39:7093-105. [PMID: 33024276 DOI: 10.1038/s41388-020-01490-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
2 Qiang W, Dai Y, Xing X, Sun X. Identification of a metabolic reprogramming-related signature associated with prognosis and immune microenvironment of head and neck squamous cell carcinoma by in silico analysis. Cancer Med 2022. [PMID: 35301800 DOI: 10.1002/cam4.4670] [Reference Citation Analysis]
3 Xiong M, Pan B, Wang X, Nie J, Pan Y, Sun H, Xu T, Cho WC, Wang S, He B. Susceptibility of Genetic Variations in Methylation Pathway to Gastric Cancer. PGPM 2022;Volume 15:441-8. [DOI: 10.2147/pgpm.s340941] [Reference Citation Analysis]
4 Wang X, Xiong M, Pan B, Cho WCS, Zhou J, Wang S, He B. Association Between SNPs in the One-Carbon Metabolism Pathway and the Risk of Female Breast Cancer in a Chinese Population. Pharmgenomics Pers Med 2022;15:9-16. [PMID: 35046699 DOI: 10.2147/PGPM.S328612] [Reference Citation Analysis]